Toposar Injection 100 mg/5 ml contains Etoposide 100 mg, a potent chemotherapeutic agent used in the treatment of various malignancies. Etoposide belongs to the class of topoisomerase II inhibitors, which disrupt DNA replication in rapidly dividing cancer cells, leading to apoptosis and tumor reduction.
Toposar Injection is specifically formulated for intravenous administration, providing precise dosing and rapid delivery for patients requiring hospital-based or outpatient chemotherapy. It is frequently used in combination with other chemotherapy drugs to enhance therapeutic efficacy in cancers such as small-cell lung cancer, testicular cancer, lymphomas, and acute myeloid leukemia.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Etoposide 100 mg per 5 ml (20 mg/ml)
Etoposide acts by targeting the enzyme topoisomerase II, which is essential for DNA replication and repair:
Inhibition of topoisomerase II – Prevents the re-ligation of DNA strands during replication, resulting in DNA strand breaks.
Induction of apoptosis – Accumulated DNA damage triggers programmed cell death in rapidly dividing cancer cells.
Cell cycle arrest – Etoposide primarily affects cells in the S and G2 phases, halting proliferation of malignant cells.
Through these mechanisms, Toposar Injection effectively reduces tumor growth and contributes to long-term cancer management.
Toposar Injection 100 mg/5 ml is indicated for:
Small-cell lung cancer – as monotherapy or part of combination chemotherapy regimens
Testicular cancer – particularly in patients resistant to other treatments
Hodgkin and non-Hodgkin lymphoma – as part of combination therapy
Acute myeloid leukemia (AML) – in induction or consolidation therapy
Other malignancies for which Etoposide is clinically indicated
It is administered under strict medical supervision with careful monitoring for side effects and therapeutic response.
Dosage is individualized based on body surface area, type of cancer, and concurrent therapies.
Toposar Injection is administered intravenously, typically over 30–60 minutes, depending on the prescribed regimen.
Ensure proper dilution and infusion rates as per protocol to minimize vein irritation and local toxicity.
Regular monitoring of blood counts, liver function, and kidney function is essential during therapy.
Patients should remain under close supervision during and after infusion for signs of adverse reactions.
Provides potent cytotoxic action against various cancers
Rapid intravenous delivery ensures precise dosing and controlled administration
Can be combined with other chemotherapeutic agents to improve outcomes
Targets rapidly dividing cancer cells, helping to reduce tumor burden
Supports comprehensive cancer treatment plans to improve survival and quality of life
Avoid in patients with severe bone marrow suppression, active infections, or known hypersensitivity to Etoposide.
Monitor liver and kidney function regularly, as dose adjustments may be necessary in impaired patients.
Avoid live vaccines during treatment.
Patients should report any signs of bleeding, infection, or unusual fatigue immediately.
Pregnancy and breastfeeding are contraindicated unless under strict medical supervision.
Common side effects:
Nausea, vomiting, and diarrhea
Hair loss (alopecia)
Fatigue and weakness
Decreased blood counts (anemia, neutropenia, thrombocytopenia)
Mouth sores or mucositis
Serious side effects requiring urgent attention:
Severe infections due to immunosuppression
Uncontrolled bleeding or bruising
Allergic reactions, including rash or anaphylaxis
Shortness of breath or chest discomfort
Store below 25°C in a cool, dry place
Protect from light and moisture
Keep the vial tightly closed until use
Keep out of reach of children
Toposar Injection 100 mg/5 ml is a highly effective intravenous chemotherapy agent for managing multiple cancers, delivering precise and rapid treatment under careful oncologist supervision.
Login Or Registerto submit your questions to seller
No none asked to seller yet